A carregar...
Emerging oral immunomodulating agents – focus on teriflunomide for the treatment of multiple sclerosis
Treatment for multiple sclerosis (MS), a chronic disease of the central nervous system, has historically relied exclusively on the use of injectable therapies. As the disease requires lifelong therapy, the development of oral therapies that are safe and effective would provide a more convenient dosa...
Na minha lista:
| Publicado no: | Degener Neurol Neuromuscul Dis |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6065561/ https://ncbi.nlm.nih.gov/pubmed/30890875 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DNND.S29022 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|